$SQURPHARMA #Square Pharmaceuticals Ltd Square Pharmaceuticals: Q3 FY 20 – NPAT grows c16% yoy due to sales growth and margin expansion: Q3 FY20 revenue growth stood at c11% yoy; SQUARE may outperform its peers during the pandemic. During… https://t.co/O3mLsiIfFt #equity #stocks https://t.co/pcsR0tBDyr